1. Peterson KD, Keefe TJ. Effects of meloxicam on severity of lameness and other clinical signs of osteoarthritis in dogs. J Am Vet Med Assoc 2004; 225:1056–1060.

1. Peterson KDKeefe TJ. Effects of meloxicam on severity of lameness and other clinical signs of osteoarthritis in dogs. J Am Vet Med Assoc 2004; 225:1056–1060.)| false
• Search Google Scholar
• Export Citation

2. Benton HP, Vasseur PB, Broderick-Villa GA, et al. Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes. Am J Vet Res 1997; 58:286–292.

2. Benton HPVasseur PBBroderick-Villa GA, et al. Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes. Am J Vet Res 1997; 58:286–292.)| false
• Search Google Scholar
• Export Citation

3. Dvorak LD, Cook JL, Kreeger JM, et al. Effects of carprofen and dexamethasone on canine chondrocytes in a three-dimensional culture model of osteoarthritis. Am J Vet Res 2002; 63:1363–1369.

3. Dvorak LDCook JLKreeger JM, et al. Effects of carprofen and dexamethasone on canine chondrocytes in a three-dimensional culture model of osteoarthritis. Am J Vet Res 2002; 63:1363–1369.)| false
• Search Google Scholar
• Export Citation

4. Collier S, Ghosh P. Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage explant and chondrocyte monolayer cultures. Biochem Pharmacol 1991; 41:1375–1384.

4. Collier SGhosh P. Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage explant and chondrocyte monolayer cultures. Biochem Pharmacol 1991; 41:1375–1384.)| false
• Search Google Scholar
• Export Citation

5. Ghosh P. Nonsteroidal anti-inflammatory drugs and chondro-protection. A review of the evidence. Drugs 1993; 46:834–846.

5. Ghosh P. Nonsteroidal anti-inflammatory drugs and chondro-protection. A review of the evidence. Drugs 1993; 46:834–846.)| false
• Search Google Scholar
• Export Citation

6. Henrotin Y, Bassleer C, Reginster JY, et al. Effects of etodolac on human chondrocytes cultivated in three dimensional culture. Clin Rheumatol 1989; 8(suppl 1):36–42.

6. Henrotin YBassleer CReginster JY, et al. Effects of etodolac on human chondrocytes cultivated in three dimensional culture. Clin Rheumatol 1989; 8(suppl 1):36–42.)| false
• Search Google Scholar
• Export Citation

7. Rainsford KD, Ying C, Smith FC. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture. J Pharm Pharmacol 1997; 49:991–998.

7. Rainsford KDYing CSmith FC. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture. J Pharm Pharmacol 1997; 49:991–998.)| false
• Search Google Scholar
• Export Citation

8. Redini F, Mauviel A, Loyau G, et al. Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. II: glycosaminoglycan synthesis. Agents Actions 1990; 31:358–367.

8. Redini FMauviel ALoyau G, et al. Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. II: glycosaminoglycan synthesis. Agents Actions 1990; 31:358–367.)| false
• Search Google Scholar
• Export Citation

9. Wilbrink B, Van der Veen MJ, Huber J, et al. In vitro influence of ketoprofen on the proteoglycan metabolism of human normal and osteoarthritis cartilage. Agents Actions 1991; 32:154–159.

9. Wilbrink BVan der Veen MJHuber J, et al. In vitro influence of ketoprofen on the proteoglycan metabolism of human normal and osteoarthritis cartilage. Agents Actions 1991; 32:154–159.)| false
• Search Google Scholar
• Export Citation

10. Palmoski MJ, Brandt KD. Proteoglycan depletion, rather than fibrillation, determines the effects of salicylate and indomethacin on osteoarthritic cartilage. Arthritis Rheum 1985; 28:548–553.

10. Palmoski MJBrandt KD. Proteoglycan depletion, rather than fibrillation, determines the effects of salicylate and indomethacin on osteoarthritic cartilage. Arthritis Rheum 1985; 28:548–553.)| false
• Search Google Scholar
• Export Citation

11. Palmoski MJ, Brandt KD. Aspirin aggravates the degeneration of canine joint caused by immobilization. Arthritis Rheum 1982; 25:1333–1342.

11. Palmoski MJBrandt KD. Aspirin aggravates the degeneration of canine joint caused by immobilization. Arthritis Rheum 1982; 25:1333–1342.)| false
• Search Google Scholar
• Export Citation

12. Manicourt DH, Druetz-Van Egeren A, Haazen L, et al. Effects of temoxicam and aspirin on the metabolism of proteoglycans and hyaluronan in normal and osteoarthritic human articular cartilage. Br J Pharmacol 1994; 113:1113–1120.

12. Manicourt DHDruetz-Van Egeren AHaazen L, et al. Effects of temoxicam and aspirin on the metabolism of proteoglycans and hyaluronan in normal and osteoarthritic human articular cartilage. Br J Pharmacol 1994; 113:1113–1120.)| false
• Search Google Scholar
• Export Citation

13. Bassleer C, Magotteaux J, Geenen V, et al. Effects of meloxicam compared to acetylsalicylic acid in human articular chondrocytes. Pharmacology 1997; 54:49–56.

13. Bassleer CMagotteaux JGeenen V, et al. Effects of meloxicam compared to acetylsalicylic acid in human articular chondrocytes. Pharmacology 1997; 54:49–56.)| false
• Search Google Scholar
• Export Citation

14. Blot L, Marcelis A, Devogelaer JP, et al. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage. Br J Pharmacol 2000; 131:1413–1421.

14. Blot LMarcelis ADevogelaer JP, et al. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage. Br J Pharmacol 2000; 131:1413–1421.)| false
• Search Google Scholar
• Export Citation

15. Giannoni P, Crovace A, Malpeli M, et al. Species variability in the differentiation potential of in vitro-expanded articular chondrocytes restricts predictive studies on cartilage repair using animal models. Tissue Eng 2005; 11:237–248.

15. Giannoni PCrovace AMalpeli M, et al. Species variability in the differentiation potential of in vitro-expanded articular chondrocytes restricts predictive studies on cartilage repair using animal models. Tissue Eng 2005; 11:237–248.)| false
• Search Google Scholar
• Export Citation

16. Webber RJ, Malemud CJ, Sokoloff L. Species differences in cell culture of mammalian articular chondrocytes. Calcif Tissue Res 1977; 23:61–66.

16. Webber RJMalemud CJSokoloff L. Species differences in cell culture of mammalian articular chondrocytes. Calcif Tissue Res 1977; 23:61–66.)| false
• Search Google Scholar
• Export Citation

17. Jovanovic DV, Fernandes JC, Martel-Pelletier J, et al. In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: suppression of collagenase 1 and interleukin-1beta synthesis. Arthritis Rheum 2001; 44:2320–2330.

17. Jovanovic DVFernandes JCMartel-Pelletier J, et al. In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: suppression of collagenase 1 and interleukin-1beta synthesis. Arthritis Rheum 2001; 44:2320–2330.)| false
• Search Google Scholar
• Export Citation

18. Mastbergen SC, Marijnissen AC, Vianen ME, et al. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology (Oxford) 2006; 45:405–413.

18. Mastbergen SCMarijnissen ACVianen ME, et al. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology (Oxford) 2006; 45:405–413.)| false
• Search Google Scholar
• Export Citation

19. Pelletier JP, Boileau C, Boily M, et al. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res Ther 2005; 7:R1091–R1102.

19. Pelletier JPBoileau CBoily M, et al. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res Ther 2005; 7:R1091–R1102.)| false
• Search Google Scholar
• Export Citation

20. Pelletier JP, Lajeunesse D, Jovanovic DV, et al. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. J Rheumatol 2000; 27:2893–2902.

20. Pelletier JPLajeunesse DJovanovic DV, et al. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. J Rheumatol 2000; 27:2893–2902.)| false
• Search Google Scholar
• Export Citation

21. Ding C. Do NSAIDs affect the progression of osteoarthritis? Inflammation 2002; 26:139–142.

21. Ding C. Do NSAIDs affect the progression of osteoarthritis? Inflammation 2002; 26:139–142.)| false
• Search Google Scholar
• Export Citation

22. Beluche LA, Bertone AL, Anderson DE, et al. Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism. Am J Vet Res 2001;62:1916–1921.

22. Beluche LABertone ALAnderson DE, et al. Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism. Am J Vet Res 2001;62:1916–1921.)| false
• Search Google Scholar
• Export Citation

23. Yuan Y, Chen XY, Wei XY, et al. Pharmacokinetic studies of meloxicam following oral and transdermal administration in Beagle dogs. Acta Pharmacol Sin 2009; 30:1060–1064.

23. Yuan YChen XYWei XY, et al. Pharmacokinetic studies of meloxicam following oral and transdermal administration in Beagle dogs. Acta Pharmacol Sin 2009; 30:1060–1064.)| false
• Search Google Scholar
• Export Citation

24. Stoker AM, Cook JL, Kuroki K, et al. Site-specific analysis of gene expression in early osteoarthritis using the Pond-Nuki model in dogs. J Orthop Surg Res [serial online]. 2006; 1:8. Available at: www.josr-online.com/content/1/1/8. Accessed Oct 10, 2006.

24. Stoker AMCook JLKuroki K, et al. Site-specific analysis of gene expression in early osteoarthritis using the Pond-Nuki model in dogs. J Orthop Surg Res [serial online]. 2006; 1:8. Available at: www.josr-online.com/content/1/1/8. Accessed Oct 10, 2006.)| false
• Search Google Scholar
• Export Citation

25. Farndale RW, Buttle DJ, Barret AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986; 883:173–177.

25. Farndale RWButtle DJBarret AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986; 883:173–177.)| false
• Search Google Scholar
• Export Citation

26. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996; 29:225–229.

26. Reddy GKEnwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996; 29:225–229.)| false
• Search Google Scholar
• Export Citation

27. Chadwick RB, Conrad MP, McGinnis MD, et al. Heterozygote and mutation detection by direct automated fluorescent DNA sequencing using a mutant Taq DNA polymerase. Biotechniques 1996; 20:676–683.

27. Chadwick RBConrad MPMcGinnis MD, et al. Heterozygote and mutation detection by direct automated fluorescent DNA sequencing using a mutant Taq DNA polymerase. Biotechniques 1996; 20:676–683.)| false
• Search Google Scholar
• Export Citation

28. Matyas JR, Atley L, Ionescu M, et al. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 2004; 50:543–552.

28. Matyas JRAtley LIonescu M, et al. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 2004; 50:543–552.)| false
• Search Google Scholar
• Export Citation

29. Hanks BC, Kuroki K, Stoker AM, et al. Evaluation of anti-inflammatory and chondroprotective effects of peroxisome proliferator-activated receptor gamma agonists in cartilage and synovial explants from dogs. Am J Vet Res 2010; 71:1142–1147.

29. Hanks BCKuroki KStoker AM, et al. Evaluation of anti-inflammatory and chondroprotective effects of peroxisome proliferator-activated receptor gamma agonists in cartilage and synovial explants from dogs. Am J Vet Res 2010; 71:1142–1147.)| false
• Search Google Scholar
• Export Citation

30. Breshears LA, Cook JL, Stoker AM, et al. Detection and evaluation of matrix metalloproteinases involved in cruciate ligament disease in dogs using multiplex bead technology. Vet Surg 2010; 39:306–314.

30. Breshears LACook JLStoker AM, et al. Detection and evaluation of matrix metalloproteinases involved in cruciate ligament disease in dogs using multiplex bead technology. Vet Surg 2010; 39:306–314.)| false
• Search Google Scholar
• Export Citation

31. Alvarez-Soria MA, Herrero-Beaumont G, Sánchez-Pernaute O, et al. Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast: comparison to its effects on osteoarthritic chondrocytes. Rheumatology 2008; 47:627–633.

31. Alvarez-Soria MAHerrero-Beaumont GSánchez-Pernaute O, et al. Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast: comparison to its effects on osteoarthritic chondrocytes. Rheumatology 2008; 47:627–633.)| false
• Search Google Scholar
• Export Citation

32. Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 2004;(suppl 427):S37–S46.

32. Goldring MBBerenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 2004;(suppl 427):S37–S46.)| false
• Search Google Scholar
• Export Citation

33. Hardy MM, Seibert K, Manning PT, et al. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum 2002; 46:1789–1803.

33. Hardy MMSeibert KManning PT, et al. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum 2002; 46:1789–1803.)| false
• Search Google Scholar
• Export Citation

34. Martel-Pelletier J, Pelletier J, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003; 33:155–167.

34. Martel-Pelletier JPelletier JFahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003; 33:155–167.)| false
• Search Google Scholar
• Export Citation

35. Kühn K, D'Lima DD, Hashimoto S, et al. Cell death in cartilage—review. Osteoarthritis Cartilage 2004; 12:1–16.

35. Kühn KD'Lima DDHashimoto S, et al. Cell death in cartilage—review. Osteoarthritis Cartilage 2004; 12:1–16.)| false
• Search Google Scholar
• Export Citation

36. Amin AR, Attur M, Patel RN, et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997; 99:1231–1237.

36. Amin ARAttur MPatel RN, et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997; 99:1231–1237.)| false
• Search Google Scholar
• Export Citation

37. Jeon JE, Schrobback K, Hutmacher DW, et al. Dynamic compression improves biosynthesis of human zonal chondrocytes from osteoarthritis patients. Osteoarthritis Cartilage 2012; 20:906–915.

37. Jeon JESchrobback KHutmacher DW, et al. Dynamic compression improves biosynthesis of human zonal chondrocytes from osteoarthritis patients. Osteoarthritis Cartilage 2012; 20:906–915.)| false
• Search Google Scholar
• Export Citation

38. Hogrefe C, Joos H, Maheswaran V, et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-multidirectional therapeutic approaches. Int J Mol Med 2012; 30:1225–1232.

38. Hogrefe CJoos HMaheswaran V, et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-multidirectional therapeutic approaches. Int J Mol Med 2012; 30:1225–1232.)| false
• Search Google Scholar
• Export Citation

39. Huskisson EC, Berry H, Gishen P, et al. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis. J Rheumatol 1995; 22:1941–1946.

39. Huskisson ECBerry HGishen P, et al. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis. J Rheumatol 1995; 22:1941–1946.)| false
• Search Google Scholar
• Export Citation